Newsmax director granted 23,940 stock options

Newsmax Inc. director Christopher Nixon Cox received a grant of 23,940 stock options.

Accepted by SEC EDGAR 05/21/2026 - 04:57 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Newsmax Inc. director Christopher Nixon Cox received a grant of 23,940 stock options. These options give him the right to buy 23,940 shares of Class B common stock at an exercise price of $7.31 per share.

The options were granted under Newsmax’s 2025 Omnibus Equity Incentive Plan at no upfront cost and will become exercisable on the 12‑month anniversary of the May 20, 2026 grant date, as long as he continues providing services to the company. After this grant, he holds 23,940 options directly.

Insider Trade Summary

Grant/Award: 23,940 shares

Grant/Award 1 txn

Insider Cox Christopher Nixon

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Option (Right to Buy)	23,940	$0.00	$0.00

Holdings After Transaction: Option (Right to Buy) — 23,940 contracts (Direct)

Holdings Before and After: Option (Right to Buy), 0 to 23,940 contracts (Direct)

Footnotes (1)

1. F1. The option was granted pursuant to the Issuer's 2025 Omnibus Equity Incentive Plan and a Stock Option Grant Notice and Option Agreement. The option shall become exercisable on the 12-month anniversary of the grant date, provided that the Reporting Person continues to provide services to the Issuer through such date.

Key Figures

Option grant size: 23,940 options Exercise price: $7.31 per share Underlying shares: 23,940 shares +3 more

6 metrics

Option grant size 23,940 options Grant of options on Class B Common Stock

Exercise price $7.31 per share Conversion or exercise price of the options

Underlying shares 23,940 shares Class B Common Stock underlying the options

Holdings after grant 23,940 options Total options held following this transaction

Grant date May 20, 2026 Date the option award was granted

Vesting condition 12-month service requirement Becomes exercisable on 12-month anniversary of grant

Key Terms

Option (Right to Buy), 2025 Omnibus Equity Incentive Plan, Stock Option Grant Notice and Option Agreement, Class B Common Stock

4 terms

Option (Right to Buy) financial

"security_title: Option (Right to Buy)"

2025 Omnibus Equity Incentive Plan financial

"The option was granted pursuant to the Issuer's 2025 Omnibus Equity Incentive Plan"

Stock Option Grant Notice and Option Agreement financial

"and a Stock Option Grant Notice and Option Agreement."

Class B Common Stock financial

"underlying_security_title: Class B Common Stock"

A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Newsmax (NMAX) disclose about Christopher Nixon Cox’s latest equity grant?

Newsmax disclosed that director Christopher Nixon Cox received 23,940 stock options. These options allow him to buy Class B common shares at $7.31 per share, granted under the 2025 Omnibus Equity Incentive Plan at no upfront cost, subject to standard vesting conditions.

How many Newsmax (NMAX) options did Christopher Nixon Cox receive and at what price?

Christopher Nixon Cox received 23,940 Newsmax stock options with a $7.31 exercise price. Each option covers one share of Class B common stock, giving him a future purchase right if the options vest and he chooses to exercise them.

When do Christopher Nixon Cox’s Newsmax (NMAX) stock options vest?

The 23,940 Newsmax stock options granted to Christopher Nixon Cox vest on the 12‑month anniversary of the May 20, 2026 grant date. Vesting requires that he continue to provide services to Newsmax through that one‑year anniversary date.

What plan governs Christopher Nixon Cox’s new Newsmax (NMAX) option award?

The option award to Christopher Nixon Cox was granted under Newsmax’s 2025 Omnibus Equity Incentive Plan. It is also documented in a Stock Option Grant Notice and Option Agreement, which together define the option’s terms, including vesting and exercisability conditions.

Does Christopher Nixon Cox hold his Newsmax (NMAX) options directly or indirectly?

Christopher Nixon Cox holds his 23,940 Newsmax stock options directly. The Form 4 identifies his ownership type and code as direct, meaning the options are not reported as being held through a separate trust, fund, or other intermediary entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cox Christopher Nixon

(Last) (First) (Middle)

C/O NEWSMAX INC.

750 PARK OF COMMERCE DR., SUITE 100

(Street)

BOCA RATON FLORIDA 33487

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Newsmax Inc. [ NMAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Buy)	$7.31	05/20/2026		A		23,940		05/20/2027(1)	05/20/0036	Class B Common Stock	23,940	$0	23,940	D

Explanation of Responses:

1. The option was granted pursuant to the Issuer's 2025 Omnibus Equity Incentive Plan and a Stock Option Grant Notice and Option Agreement. The option shall become exercisable on the 12-month anniversary of the grant date, provided that the Reporting Person continues to provide services to the Issuer through such date.

Remarks:

	/s/ Darryle Burnham as Attorney-In-Fact for Christopher Nixon Cox	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)